Pfizer (PFE) upsized its offering of Haleon (HLN) shares to 640M shares from about 540M, according to Bloomberg, citing terms of the deal seen by the news service.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Pfizer intends to sell about 540M ordinary shares in Haleon
- Morgan Stanley removes Haleon as Top Pick, ups price target
- Haleon launches Eroxon gel for erectile dysfunction
- Haleon PLC Sponsored ADR (HLN) Unveils Dividend Details for Q3: Mark Your Calendar!
- Haleon U.S. shares initiated with a Buy at Berenberg